Could haemochromatosis ( HFE ) gene mutations affect response to iron chelation in myelodysplastic syndrome? – Response to Lucijanic and Kusec-Reference-Cited by-同舟云学术

Could haemochromatosis ( HFE ) gene mutations affect response to iron chelation in myelodysplastic syndrome? – Response to Lucijanic and Kusec

Published:2019-05 Issue:4 Volume:186 Page:639-640
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Fabiani Emiliano¹^ORCID,Valentini Lia¹,Cilloni Daniela²,Voso Maria T.¹^ORCID

Affiliation:

1. Department of Biomedicine and Prevention Universita' Tor Vergata Rome Italy

2. Department of Clinical and Biological Sciences University of Turin Orbassano Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15938

Reference5 articles.

1. HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross‐sectional study;De Souza G.F.;British Medical Journal Open,2015

2. Mutational profile and haematological response to iron chelation in myelodysplastic syndromes ( MDS )

3. Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data

4. Prevalence of the C282Y and H63D polymorphisms in a multi‐ ethnic control population;Marchall D.S.;International Journal of Molecular Medicine,1999

5. Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients;Journal of Blood Medicine;2021-12